Showing results (1-10 of 26) with videos related to
Sort By:
Pageof 3
Diabetes & Metabolism|February 5, 1999
Role of apolipoprotein CIII in triglyceride-rich lipoprotein metabolismA FredenrichBulletin De L'Academie Nationale De Medecine|July 28, 2001
[Clinical, epidemiologic, and biochemical findings on the reverse cholesterol transport (cholesterol-HDL)]A Fredenrich, P BayerDiabetes & Metabolism|August 12, 2003
Reverse cholesterol transport, high density lipoproteins and HDL cholesterol: recent dataA Fredenrich, P BayerDiabetes & Metabolism|April 2, 2005
PPAR delta: an uncompletely known nuclear receptorA Fredenrich, P A GrimaldiArchives Des Maladies Du Coeur Et Des Vaisseaux|September 1, 1992
[Hypolipidemic treatment after myocardial infarction]P Morand, J P Roquebrune, A FredenrichDiabetes & Metabolism|September 6, 2005
Combination of apolipoprotein E2 and lipoprotein lipase heterozygosity causes severe hypertriglyceridemia during pregnancyS Hiéronimus, P Benlian, P Bayer, et al.Annales D'Endocrinologie|October 28, 1998
[Late recurrence of subacute De Quervain-Crile thyroiditis]A Fredenrich, S Hieronimus, Y Carré, et al.Metabolism: Clinical and Experimental|February 15, 2001
Lipoprotein distribution of apolipoprotein C-III and its relationship to the presence in plasma of triglyceride-rich remnant lipoproteinsC Marcoux, M Tremblay, A Fredenrich, et al.Revue Neurologique|June 21, 2008
[Paraneoplastic limbic encephalitis with positive anti-RI antibodies and mediastinal seminoma]M Launay, E Bozzolo, N Venissac, et al.Atherosclerosis|January 27, 1999
Effects of low density and high density lipoproteins isolated from non-insulin dependent diabetic patients on prostaglandin secretion by mouse macrophage cell line P388D1A Fredenrich, D Jambou, P Bayer, et al.Pageof 3